This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (64)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effect on Levels of Intercellular Antibodies in Pemphigus Vulgaris

Robert Auerbach, MD; Jean-Claude Bystryn, MD

Arch Dermatol. 1979;115(6):728-730.

Abstract
A patient with pemphigus vulgaris and serious side effects of steroid therapy was treated by exchange plasmapheresis. Eight plasmaphereses were performed over six weeks. Each procedure reduced the serum level of intercellular antibodies by 50% to 87%. A rebound in levels of intercellular antibodies usually followed their depletion but could be minimized or completely suppressed by administration of cyclophosphamide. After six weeks of therapy, clinical symptoms had greatly improved and intercellular antibody levels had decreased from a titer of 5,120 to 160. It is not possible to ascribe these improvements specifically to plasmapheresis since the patient was concurrently receiving low doses of prednisone and intermittent treatment with cyclophosphamide.

(Arch Dermatol 115:728-730, 1979)

Author Affiliations
From the Immunofluorescence Laboratory, Department of Dermatology, New York University School of Medicine, New York.

Footnotes
Accepted for publication Jan 30, 1979.

Reprint requests to Department of Dermatology, New York University School of Medicine, 560 First Ave, New York, NY 10016 (Dr Bystryn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improvement of Intravenous Immunoglobulin Therapy for Bullous Pemphigoid by Adding Immunosuppressive Agents: Marked Improvement in Depletion of Circulating Autoantibodies
Czernik and Bystryn
Arch Dermatol 2008;144:658-661.
ABSTRACT | FULL TEXT  

The Adjuvant Therapy of Pemphigus: An Update
Bystryn and Steinman
Arch Dermatol 1996;132:203-212.
ABSTRACT  

Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT  

Controlled Study of Plasma Exchange in Pemphigus
Guillaume et al.
Arch Dermatol 1988;124:1659-1663.
ABSTRACT  

Plasmapheresis Therapy of Pemphigus
Bystryn
Arch Dermatol 1988;124:1702-1704.
ABSTRACT  

Pemphigus Vulgaris: Combined Treatment With Intravenous Corticosteroid Pulse Therapy, Plasmapheresis, and Azathioprine
Fine et al.
Arch Dermatol 1988;124:236-239.
ABSTRACT  

Synchronization of Plasmapheresis and Pulse Cyclophosphamide Therapy in Pemphigus Vulgaris
Euler et al.
Arch Dermatol 1987;123:1205-1210.
ABSTRACT  

Adjuvant Therapy of Pemphigus
Bystryn
Arch Dermatol 1984;120:941-951.
ABSTRACT  

Mechanisms of Immunologic Injury: Pemphigus and Bullous Pemphigoid
Anhalt et al.
Arch Dermatol 1983;119:711-714.
ABSTRACT  

Small Volume Plasmapheresis in the Management of Porphyria Cutanea Tarda
Miyauchi et al.
Arch Dermatol 1983;119:752-755.
ABSTRACT  

Plasma Exchange in Pemphigus: Uncontrolled Study of Ten Patients
Roujeau et al.
Arch Dermatol 1983;119:215-221.
ABSTRACT  

Acanthosis Nigricans Developing in Resolving Lesions of Pemphigus Vulgaris
Coverton and Armstrong
Arch Dermatol 1982;118:115-116.
ABSTRACT  

Pemphigus: Current Concepts
AHMED et al.
ANN INTERN MED 1980;92:396-405.
ABSTRACT